[N-(1-Methyl-2-phenylethyl)-3,3-diphenyl-propylamine, a new synthetic substance for the treatment, from the etiopathogenic viewpoint, of myocardiopathies caused by coronary insufficiency].
D001713:Biphenyl Compounds; D009202:Cardiomyopathies; D003324:Coronary Artery Disease; D003327:Coronary Disease / Q000628:therapy*; D010627:Phenethylamines / Q000628:therapy*; D011437:Propylamines; D014665:Vasodilator Agents / Q000628:therapy*
D001713:Biphenyl Compounds; D010627:Phenethylamines; D011437:Propylamines; D014665:Vasodilator Agents; C010574:biphenyl
CORONARY DISEASE/therapy; PHENYLETHYLAMINES/therapy; VASODILATOR AGENTS/therapy